STOCKHOLDERS' DEFICIT (Details 3) - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| 2011 Stock Incentive Option Plan [Member] | ||
| Class Of Warrant Or Right [Line Items] | ||
| Number of Options outstanding, beginning | 5,968,338 | 7,110,025 |
| Number of Options, Cancelled, forfeited and expired | (1,307,551) | (1,141,687) |
| Number of Options outstanding, end | 4,660,787 | 5,968,338 |
| Number of Options, Options exercisable | 4,645,286 | 5,937,837 |
| Number of Options, Options available for future grant | 4,000,000 | |
| Weighted-Average Exercise Price, Options outstanding, beginning | $ 4.78 | $ 4.63 |
| Weighted-Average Exercise Price, Cancelled, forfeited and expired | 3.73 | 3.82 |
| Weighted-Average Exercise Price, Options outstanding, end | 5.08 | 4.78 |
| Weighted-Average Exercise Price, Options exercisable | $ 5.10 | $ 4.80 |
| 2021 Stock Incentive Option Plan [Member] | ||
| Class Of Warrant Or Right [Line Items] | ||
| Number of Options, Options available for future grant | 4,000,000 | |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted average price of options that were either forfeited or expired. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|